| Literature DB >> 9515582 |
A L Bodley1, J N Cumming, T A Shapiro.
Abstract
Currently, the treatment of falciparum malaria is seriously compromised by spreading drug resistance. We studied the effects of camptothecin, a potent and specific topoisomerase I inhibitor, on erythrocytic malaria parasites in vitro. In Plasmodium falciparum, camptothecin trapped protein-DNA complexes, inhibited nucleic acid biosynthesis, and was cytotoxic. These results provide proof for the concept that topoisomerase I is a vulnerable target for new antimalarial drug development.Entities:
Mesh:
Substances:
Year: 1998 PMID: 9515582 DOI: 10.1016/s0006-2952(97)00556-x
Source DB: PubMed Journal: Biochem Pharmacol ISSN: 0006-2952 Impact factor: 5.858